药品名称PLETAL
申请号020863产品号001
活性成分CILOSTAZOL市场状态停止上市
剂型或给药途径TABLET;ORAL规格50MG
治疗等效代码参比药物
批准日期1999/01/15申请机构OTSUKA PHARMACEUTICAL CO LTD
化学类型New molecular entity (NME)审评分类Standard review drug
与本品相关的专利信息(来自橙皮书Orange Book)
专利号专利过期日是否化合物专利是否产品专利专利用途代码专利下载
历史专利信息
与本品相关的市场独占权保护信息
独占权代码失效日期
历史市场独占权保护信息
与药品注册相关的信息
申请号修订号审批结论公开文档类型文档创建时间获取文档
020863023APLetter2015/07/31下载
020863023APLabel2015/08/04下载
020863022APLetter2015/01/26下载
020863022APLabel2015/01/29下载
020863021APLabel2007/11/19下载
020863021APLetter2007/11/19下载
020863019APLabel2007/01/24下载
020863019APLetter2007/01/25下载
020863011APLabel2005/11/30下载
020863011APLetter2005/11/30下载
020863007APLetter2004/03/03下载
020863000APLabel2004/06/14下载
020863000APLetter1999/01/15下载
020863000APReview1999/01/15下载
药品注册审批历史信息
申请号修订号审批结论审批日期审批内容
020863023AP2015/07/30Labeling Revision
020863022AP2015/01/23Labeling Revision
020863021AP2007/11/13Labeling Revision
020863019AP2007/01/18Efficacy Supplement with Clinical Data to Support
020863011AP2005/11/23Labeling Revision
020863008AP2002/09/20Manufacturing Change or Addition
020863007AP2004/02/04Labeling Revision
020863006AP2001/03/07Control Supplement
020863005AP2000/12/27Manufacturing Change or Addition
020863004AP2000/07/07Manufacturing Change or Addition
020863003AP2000/06/26Control Supplement
020863002AP2000/02/16Control Supplement
020863001AP1999/03/31Manufacturing Change or Addition
020863000AP1999/01/15Approval